Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT02011750
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent
* Adult men or women (ages 18-50 years)
* Schizophrenia / schizoaffective disorder (DSM IV)
* Duration of illness \< 5 years (since onset of psychosis)
* On a stable dose of an antipsychotic for at least a month
* Scores 4 or more on at least one item of the Positive and Negative Syndrome Scale.
Exclusion Criteria:
* Substance abuse in the past month/dependence past 6 months
* History of / or current medical/neurological illnesses e.g. mental retardation (DSM-IV) or epilepsy;
* Medical conditions that are judged by the consulting internist and research staff to be unstable
* Pregnant or breast-feeding women
* Known allergy or serious adverse event to DEP, Received Chlorpromazine, Trimethoprim or DEP for up to 6 months prior to study entry.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT02011750
Study Brief:
Protocol Section:
NCT02011750